Joint Formulary & PAD

Naldemedine - Constipation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Naldemedine
Indication :
Constipation
Group Name :
Keywords :
opioid induced constipation
Brand Names Include :
Rizmoic
Important Information :
Opioid-induced constipation. Only after other laxatives have been unsuccessful.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Naldemedine is used to treat.

  • No records returned.

Committee Recommendations (2)

The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.

Management | Constipation | CKS | NICE

The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.

Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.

The Surrey Heartlands ICS Area Prescribing Committee approves naldemedine as another treatment option for Opioid  Induced Constipation (OIC) in line with NICE TA651.

Naldemedine will be given a GREEN traffic light status for this indication.